CLARK GEORGE C. (VP, Chief Accounting Officer) sold 60.9% of their position (9.38K shares) of BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. on the open market
Open‑market sale worth $1.10M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Shares
Shares
+3.75K
Price / share
$53.76
Trade value
$201.60K
% of position
Common Shares
Shares
+1.92K
Price / share
$32.42
Trade value
$62.25K
% of position
Common Shares
Shares
−3.20K
Price / share
$114.93
Trade value
$367.31K
% of position
Common Shares
Shares
−2.16K
Price / share
$116.02
Trade value
$250.48K
% of position
Common Shares
Shares
−500.00
Price / share
$118.05
Trade value
$59.02K
% of position
Common Shares
Shares
−3.52K
Price / share
$119.37
Trade value
$420.18K
% of position
Net shares
−3.71K
Net value
-$833.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 1/19/2022 | M · Option Exercise | +3.75K | $53.76 | $201.60K | 38.6% | 9.72K | 13.47K |
| Common Shares Direct | 1/19/2022 | M · Option Exercise | +1.92K | $32.42 | $62.25K | 14.3% | 13.47K | 15.39K |
| Common Shares Direct | 1/19/2022 | S · Sale | −3.20K | $114.93 | $367.31K | 20.8% | 15.39K | 12.19K |
| Common Shares Direct | 1/19/2022 | S · Sale | −2.16K | $116.02 | $250.48K | 17.7% | 12.19K | 10.04K |
| Common Shares Direct | 1/19/2022 | S · Sale | −500.00 | $118.05 | $59.02K | 5.0% | 10.04K | 9.54K |
| Common Shares Direct | 1/19/2022 | S · Sale | −3.52K | $119.37 | $420.18K | 36.9% | 9.54K | 6.01K |
| Total | −3.71K | -$833.16K | ||||||
Employee Stock Option (right to buy)
Common Shares
3.75K shares
Shares
−3.75K
Strike price
53.76
Held after
4.50K
Exercisable
—
Employee Stock Option (right to buy)
Common Shares
1.92K shares
Shares
−1.92K
Strike price
32.42
Held after
2.88K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Shares3.75K shares | 1/19/2022 | M · Option Exercise | −3.75K | 53.76 | — | 4.50K |
| Employee Stock Option (right to buy) Direct | Common Shares1.92K shares | 1/19/2022 | M · Option Exercise | −1.92K | 32.42 | — | 2.88K |